Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein (Monomer, MALS verified)

Produktübersicht

• Artikelname: Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein (Monomer, MALS verified)
• Artikelnummer: ABS-HLC-H82E8-200UG
• Hersteller Artikelnummer: HLC-H82E8-200ug
• Alternativnummer: ABS-HLC-H82E8-200UG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Proteine/Peptide
• Spezies Reaktivität: Human
• Konjugation: Biotin

Produktbeschreibung

The peptide LLDFVRFMGV, derived from the EpsteinBarr virus nuclear antigen EBNA3C, is presented by the HLAA*02:01/beta2m complex. This peptideMHC complex serves as a major target for cytotoxic T lymphocytes (CTLs) in the immune control of EBV infection. Its robust immunogenicity makes it a key antigen of interest for studying EBVspecific Tcell responses and for developing immunotherapies against EBVassociated diseases. - Proteine/Peptide

Produkteigenschaften

• Molekulargewicht: 36.3 kDa and 13.9 kDa
• Tag: C-10*His & C-Avi
• NCBI: 59606
• Puffer: PBS, pH7.4
• Reinheit: 90%
• Formulierung: Powder
• Target-Kategorie: HLA-A*0201 & B2M & EBV EBNA3C (LLDFVRFMGV)

Bilder

Immobilized Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein (Cat. No. HLC-H82E8) at 1 µg/mL (100 µL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 µg/well) plate can bind Anti-HLA class I Antibody, Human IgG1 (W6/32) with a linear range of 0.4-3 ng/mL (QC tested).

Immobilized Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein (Cat. No. HLC-H82E8) at 1 µg/mL (100 µL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 µg/well) plate can bind Anti-B2M Antibody, Human IgG1 with a linear range of 0.2-2 ng/mL (Routinely tested).

Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.